Catalyst Pharmaceuticals Long Term Deferred Assets (Quarterly) Insights

Catalyst Pharmaceuticals, Inc. (CPRX)

23.16 +0.46 (+2.03%) USD | NASDAQ | Jan 20, 11:07

View Long Term Deferred Assets (Quarterly) for CPRX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Collegium Pharmaceutical, Inc.	Upgrade
ACADIA Pharmaceuticals, Inc.	--
Amicus Therapeutics, Inc.	--
Rigel Pharmaceuticals, Inc.	--
Krystal Biotech, Inc.	--